Cholecystokinin expression in tumors: biogenetic and diagnostic implications

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Cholecystokinin (CCK) is a classic gut hormone. CCK is also a complex system of peptides expressed in several molecular forms in enteroendocrine I cells, in cerebral and peripheral neurons, in cardiac myocytes and spermatozoa. CCK gene expression has now been found at protein or peptide level in different neuroendocrine tumors; cerebral gliomas and astrocytomas and specific pediatric tumors. Tumor hypersecretion of CCK was recently reported in a patient with a metastatic islet cell tumor and hypercholecystokininemia resulting in a novel tumor syndrome, the cholecystokininoma syndrome. This review presents an overview of the cell-specific biogenesis of CCK peptides, and a description of the CCK expression in tumors and of the cholecystokininoma syndrome. Finally, assays for the diagnosis of CCK-producing tumors are reviewed.

OriginalsprogEngelsk
TidsskriftFuture Oncology
Vol/bind12
Udgave nummer18
Sider (fra-til)2135-47
Antal sider13
ISSN1479-6694
DOI
StatusUdgivet - sep. 2016

ID: 176826933